A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
@article{White2019ARO, title={A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential}, author={C. White}, journal={The Journal of Clinical Pharmacology}, year={2019}, volume={59} }
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. Numerous CBD products are available, ranging from a US Food and Drug Administration (FDA)‐approved product called Epidiolex to products created for medical marijuana dispensaries and products sold in smoke shops, convenience stores, and over the Internet. The legal status of the non–FDA‐approved products differs depending on the source of the CBD and the state, while the consistency and quality of the… CONTINUE READING
Topics from this paper
Paper Mentions
Interventional Clinical Trial
The overarching objective of the proposed project is to test the clinical efficacy of CBD in
the treatment of post-traumatic stress disorder using a rigorous double-blind randomized… Expand
Conditions | Post Traumatic Stress Disorder |
---|---|
Intervention | Drug, Other |
Interventional Clinical Trial
The overarching objective of the proposed project is to test the relative clinical efficacy
of CBD isolate, full-spectrum CBD oil, and placebo in in reducing COVID-Induced stress… Expand
Conditions | Alcohol Abuse, Anger, Anxiety Depression, (+3 more) |
---|---|
Intervention | Dietary Supplement |
50 Citations
Therapeutic Efficacy of Cannabidiol (CBD): a Review of the Evidence From Clinical Trials and Human Laboratory Studies
- Medicine
- Current Addiction Reports
- 2020
- 1
Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements
- Medicine
- Veterinary medicine
- 2020
- 1
- PDF
Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids
- Medicine
- Pharmacology Biochemistry and Behavior
- 2020
Social Media Surveillance for Perceived Therapeutic Effects of Cannabidiol (CBD) Products
- Psychology
- 2019
- 1
- PDF
Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase 1 Clinical Trial.
- Medicine
- Clinical pharmacology and therapeutics
- 2020
References
SHOWING 1-10 OF 65 REFERENCES
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
- Medicine
- 2017
- 108
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
- Medicine
- Cannabis and cannabinoid research
- 2017
- 135
- PDF
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
- Medicine
- Journal of epilepsy research
- 2017
- 99
- PDF
Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans
- Medicine
- Journal of addiction medicine
- 2015
- 54
- PDF
Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man.
- Chemistry, Medicine
- European journal of pharmacology
- 1974
- 253
Cannabidiol: State of the art and new challenges for therapeutic applications.
- Medicine
- Pharmacology & therapeutics
- 2017
- 179
- PDF
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.
- Medicine
- Current pharmaceutical design
- 2012
- 151
Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.
- Medicine
- Epidemiology and psychiatric sciences
- 2018
- 26
- PDF
Action of cannabidiol on the anxiety and other effects produced by δ9-THC in normal subjects
- Psychology
- Psychopharmacology
- 2004
- 221
- PDF